| Authors: |
Labiano I; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Guerrero-Setas D; Molecular Pathology of Cancer Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Pathology, Hospital Universitario de Navarra (HUN), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Huerta AE; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Mata E; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain., Alkorta-Aranburu G; CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Ordoñez GR; Department of Personalized Medicine & Laboratories, NASERTIC, Government of Navarra, Pamplona, Spain., Berraondo P; Programme of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Lecumberri A; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain., Ochoa P; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain., Caseda I; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Termini R; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Agirre-Mikelarena B; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Amat I; Molecular Pathology of Cancer Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Pathology, Hospital Universitario de Navarra (HUN), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Castro N; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain., Arasanz H; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain., Alsina M; Translational Medical Oncology Unit, Navarrabiomed-Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona-Iruñea, Spain. maria.alsina.maqueda@navarra.es.; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain. maria.alsina.maqueda@navarra.es., Vera R; Department of Medical Oncology, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008, Pamplona, Spain. |
